Alzheimer’s experts call for changes in FDA drug approval standards
European Pharmaceutical Review | May 12, 2017
Leading Alzheimer’s disease researchers and a prominent patient advocate today published an analysis, Single Endpoint for New Drug Approvals for Alzheimer’s Disease, urging the Food and Drug.